Find a Tender
complete
Official procurement procedure
Supportive Medicines Phase 5a - Propofol 1g/50ml Emulsion for Infusion
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency: "Supportive Medicines Phase 5a - Propofol 1g/50ml Emulsion for Infusion". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
3.1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 134 active published awards; 82 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published17 Feb 2022, 16:52 GMT | Last source update17 Feb 2022, 16:52 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-031874 | ||
What is being bought
A requirement for the supply of 375,000 vials of Propofol 1g / 50 ml emulsion for infusion (for use in Intensive Treatment Units) in preparation for further waves of Covid 19 in Winter 2021/Spring 2022.
What changed
From the official release history
- Status changed to complete
17 Feb 2022, 16:52 GMT - Official notice release published
17 Feb 2022, 16:52 GMT - Buyer information updated
17 Feb 2022, 16:52 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe Department of Health and Social Care (DHSC) has awarded a contract for the supply of 375,000 vials of Propofol 1g / 50 ml emulsion for infusion (for use in Intensive Treatment Units) in preparation for further waves of Covid 19 in Winter 2021/Spring 2022. The contract was awarded on behalf of United Kingdom Health Security Agency (UKHSA)Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
17 Feb 2022, 16:52 GMT - Award active
Not published · Not published - Contract active
Signed 23 Jan 2022, 00:00 GMT · £1
Commercial outcome and competition
Awards B. Braun Medical Limited Not published · Not published · active |
Contracts Contract £1 · signed 23 Jan 2022, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) |
Buyer and organisations in this procedure
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Contracting authority GB-FTS-34582Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe Coronavirus disease (Covid-19) is a serious infectious respiratory disease and its consequences pose a risk to life. The Covid-19 pandemic supportive medicines stockpile was designed as a ‘one off’ build to target volumes of a defined range of critical products used within the intensive treatment units and end of life environments. However, developments in Winter 2021 around the Omicron variant and heightened risk perception within Government prompted activation of the ‘Challenging Winter Peak’ Scenario at very short notice, resulting in an urgent requirement to procure additional volumes of some critical products to avoid their complete stockout in the month of January 2022. The global stock of Propofol is limited and there are many buyers competing for the same supplies. It is imperative that security of supply is maintained for public health purposes. Due to the short delivery timeframe required to mitigate a complete stockout, the authority did not have sufficient time to comply with the standard open procedure time scales for this procurement. Accordingly, the Authority used the negotiated procedure without prior publication – Regulation 32(2)(c) – Extreme Urgency Route (i.e. direct award) permitted under the Public Contract Regulations 2015 (as amended) to conduct this procurement |